News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Andres Gomez: Venetoclax can be effectively reduced to 100 mg when combined with azoles in a first-line, phase 2 trial done under limited resources.
Photo from Andres Gomez/Twitter
Aug 29, 2023, 19:15

Andres Gomez: Venetoclax can be effectively reduced to 100 mg when combined with azoles in a first-line, phase 2 trial done under limited resources.

Andres Gomez, an Associate Professor at Universidad Autónoma de Nuevo León, Mexico, recently tweeted:

“Venetoclax is an expensive life-saving drug in AML. We have proven it can be effectively reduced to 100 mg when combined with azoles in a first-line, phase 2 trial done under limited resources.

Out now in Leuk Res, access here:”

Source: Andres Gomez/Twitter

Andres Gomez cancer OncoDaily Oncology Twitter venetoclax
Special Coverage
Blog
Feb 21, 2025, 11:52
Zainab Shinkafi-Bagudu: Exploring collaborations in cancer care with the Indian High Commission in Abuja
Blog
Feb 21, 2025, 11:51
Integrative medicine for cancer-related pain and anxiety/depression - Society for Integrative Oncology
Insight
Feb 21, 2025, 11:40
Zoë Mullan: The launch of our much-anticipated Commission on medical oxygen security
Science
Feb 21, 2025, 11:36
Myeloma Paper of the Day, February 21st, suggested by Robert Orlowski
Dialogues
Feb 21, 2025, 11:29
HPV Self-Collection for Cervical Cancer: Dr. Kay's Insights
Science
Feb 21, 2025, 11:03
George Vlachogiannis: A growing CRC burden among younger individuals in high socio-demographic index regions
Blog
Feb 21, 2025, 11:02
Divya Sachdev: Building a future where every child, no matter where they live, has a fair chance at survival
Blog
Feb 21, 2025, 10:55
Giuseppe Curigliano: Mourning the untimely passing of Giovanni Scambia - a visionary leader in European gynecologic oncology
Blog
Feb 21, 2025, 10:45
Saurabh Zanwar: Clonal plasma cell proportion in the S-phase in multiple myeloma
Blog
Feb 21, 2025, 10:37
Cihangir Akyol: A comprehensive review on colorectal ESD outcomes by Lumir Kunovsky
Celebrities
Feb 21, 2025, 10:28
In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer
Science
Feb 21, 2025, 10:07
Elai Davicioni: Predicting Dose-Response to Prostate Cancer Radiotherapy